A Randomized Phase II Study of Pembrolizumab and Brentuximab Vedotin Versus GDP, Followed by High Dose Chemotherapy and Autologous Stem...

Randomized Phase III Study of Early Intervention with Venetoclax and Obinutuzumab versus DeLayed Therapy with VEnetoclax and Obinutuzumab...

A phase I master protocol of novel combination therapy for patients with relapsed or refractory lymphoma - The RGDP-Venetoclax substudy...

Refining Adjuvant Treatment in Endometrial Cancer Based On Molecular Features Population:  Gyne - Endometrial Cancer Line of therapy:...

A Phase II Study of Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype/NSMP Early Stage Endometrial Cancer Population:  Gyne -...

An Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer (IPROC) Population:  Gyne - Serous Ovarian Cancer...

A Randomized Phase II Trial of Adjuvant Nivolumab with or without Cabozantinib in Patients with Resected Mucosal Melanoma Population:...

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-NORTH AMERICA) Population:  CRC Line of therapy:  Adjuvant...

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer Population:  ER+, HER2-...